Pan-Cancer Diagnostic Assistant
Instantaneous Guidance and Lifetime Management
Clinical decisions shouldn't be based on snapshots. PANDA unifies synchronous in-situ procedural guidance with post-procedure asynchronous clinical surveillance to provide a continuous view of the patient's journey.
By fusing live video, imaging, labs, and pathology, PANDA is useful in the endoscopy suite, the oncology tumor board, and clinical trials for endoscopic response evaluation in solid tumors.
EUS Procedure Guidance
Live guidance overlays and precise biopsy decisions
Longitudinal Monitoring
Cross-modal monitoring across care continuum.
Clinical Research and Insights
EUS response evaluation criteria in solid tumors
Not to be confused with CT-only "PANDA" models. Our platform is EUS-first, multimodal fusion — developed with Orlando Health's Digestive Health Institute and UCF's AI engineering teams, purpose-built for endoscopic and oncologic workflows.
For Endoscopists
Purpose-Built for the Endoscopy Suite
PANDA is designed to handle the high-pressure EUS environment—optimizing screen real estate and reducing cognitive load so you can focus on the patient.
Comprehensive Navigation
Real-time landmark recognition and segment checks to ensure thorough coverage and eliminate blind spots.
Precision Biopsy Targeting
AI-enhanced overlays that distinguish viable tumor tissue from necrotic or fibrotic regions for higher diagnostic yields.
.png)
Cyst Risk Stratification
Objective identification of high-risk stigmata to support confident, guideline-aligned follow-up decisions.
Seamless Workflow Integration
A streamlined, 2-click experience that keeps your eyes on the primary scope monitor, not a secondary screen.
For Oncologists
Advanced Insights for Oncology and Tumor Boards
Oncology teams need more than just one snapshot; they need a complete, longitudinal picture across all modalities. PANDA unifies diverse data into actionable insights for high-stakes decisions.
Beyond Standard RECIST
Longitudinal analytics that track tumor texture, volume, and complex biomarkers alongside standard linear measurements.
Distinguish Pseudo-Progression
Leverage multimodal AI to accurately distinguish true disease progression from immune-related flare (pseudo-progression).
Unified Case Summaries
Pre-assembled views combining pathology, imaging, and labs into clear summaries to maximize tumor board discussion time.
Transparent Clinical Decisions
See exactly which data points are driving risk scores. Our explainable AI gives you clarity on how every insight is generated.
Deployment
Designed for Comprehensive Cancer Centers and Community Referrals
Most cancer care begins in the community—but complex cases require coordination with specialized centers. PANDA connects community oncology clinics (spokes) with leading cancer institutes (hubs), enabling expert-level insights, faster referrals, and unified decision-making across the care network.
Connected Community Clinics (Spokes)
Seamlessly capture imaging, EUS data, and clinical context at community sites, where most patients first present.
Central Expert Hub (Primary Oncology Institute)
Aggregate cases at a central cancer institute for advanced AI analysis, multidisciplinary review, and specialist oversight.
Intelligent Referral & Collaboration Network
Route high-risk patients to the right specialists faster, with shared data, AI insights, and intelligent coordination across sites.